Lysins as a powerful alternative to combat Bacillus anthracis

Area of Science:

• Microbiology
• Biotechnology
• Infectious Diseases

Background:

• Bacillus anthracis causes anthrax, a severe zoonotic disease and potential biowarfare agent.
• Antibiotic treatment for anthrax is lengthy and can be compromised by various factors.
• Bacteriophage-derived lysins are enzymes that specifically kill bacterial cells.

Purpose of the Study:

• To review known lysins active against Bacillus anthracis strains.
• To summarize lysin properties and efficacy in vitro and in animal models.
• To explore lysins as an alternative to conventional antibiotic treatments.

Main Methods:

• Literature review of identified Bacillus anthracis lysins.
• Analysis of lytic properties and amino acid sequence similarity.
• Evaluation of in vitro and in vivo study outcomes.

Main Results:

• Over a dozen Bacillus anthracis lysins have been identified and characterized.
• Lysins active against B. anthracis fall into three main sequence similarity groups, primarily amidases.
• Studies demonstrate lysin activity against B. anthracis and a surrogate strain (Bacillus cereus).

Conclusions:

• Lysins represent a promising therapeutic strategy against Bacillus anthracis infections.
• Harnessing lysins can reduce reliance on antibiotics, addressing antibiotic resistance.
• Further research into lysins could lead to novel treatments for anthrax.